nodes	percent_of_prediction	percent_of_DWPC	metapath
Topotecan—CYP3A4—Pilocarpine—glaucoma	0.0826	0.166	CbGbCtD
Topotecan—ABCB1—Timolol—glaucoma	0.0792	0.159	CbGbCtD
Topotecan—ABCB1—Clonidine—glaucoma	0.0673	0.135	CbGbCtD
Topotecan—CYP3A4—Brinzolamide—glaucoma	0.0648	0.13	CbGbCtD
Topotecan—CYP3A4—Dorzolamide—glaucoma	0.0626	0.126	CbGbCtD
Topotecan—CYP3A4—Methazolamide—glaucoma	0.0558	0.112	CbGbCtD
Topotecan—CYP3A4—Acetazolamide—glaucoma	0.0446	0.0897	CbGbCtD
Topotecan—CYP3A4—Clonidine—glaucoma	0.0404	0.0811	CbGbCtD
Topotecan—TOP1—Circadian rythm related genes—ATOH7—glaucoma	0.00331	0.161	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.00222	0.108	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—OPN4—glaucoma	0.00132	0.064	CbGpPWpGaD
Topotecan—TOP1—Caspase Cascade in Apoptosis—FAS—glaucoma	0.000957	0.0465	CbGpPWpGaD
Topotecan—TOP1—Caspase Cascade in Apoptosis—BCL2L1—glaucoma	0.000903	0.0439	CbGpPWpGaD
Topotecan—ABCB1—ABC-family proteins mediated transport—PEX19—glaucoma	0.000867	0.0422	CbGpPWpGaD
Topotecan—Dyspepsia—Brimonidine—glaucoma	0.000734	0.00152	CcSEcCtD
Topotecan—Hypoaesthesia—Betaxolol—glaucoma	0.000733	0.00152	CcSEcCtD
Topotecan—Pharyngitis—Betaxolol—glaucoma	0.000731	0.00152	CcSEcCtD
Topotecan—Hyperhidrosis—Pilocarpine—glaucoma	0.000727	0.00151	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000725	0.00151	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Travoprost—glaucoma	0.000722	0.0015	CcSEcCtD
Topotecan—Gastrointestinal disorder—Brimonidine—glaucoma	0.00072	0.00149	CcSEcCtD
Topotecan—Fatigue—Brimonidine—glaucoma	0.000719	0.00149	CcSEcCtD
Topotecan—Anorexia—Pilocarpine—glaucoma	0.000717	0.00149	CcSEcCtD
Topotecan—Feeling abnormal—Acetazolamide—glaucoma	0.000716	0.00149	CcSEcCtD
Topotecan—Hypersensitivity—Apraclonidine—glaucoma	0.000716	0.00148	CcSEcCtD
Topotecan—Paraesthesia—Dorzolamide—glaucoma	0.000715	0.00148	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000713	0.00148	CcSEcCtD
Topotecan—Pain—Brimonidine—glaucoma	0.000713	0.00148	CcSEcCtD
Topotecan—Dyspnoea—Dorzolamide—glaucoma	0.00071	0.00147	CcSEcCtD
Topotecan—Muscle spasms—Clonidine—glaucoma	0.000708	0.00147	CcSEcCtD
Topotecan—Dyspnoea—Travoprost—glaucoma	0.000707	0.00147	CcSEcCtD
Topotecan—Paraesthesia—Brinzolamide—glaucoma	0.000703	0.00146	CcSEcCtD
Topotecan—Dyspepsia—Dorzolamide—glaucoma	0.000701	0.00145	CcSEcCtD
Topotecan—Dyspnoea—Brinzolamide—glaucoma	0.000698	0.00145	CcSEcCtD
Topotecan—Dyspepsia—Travoprost—glaucoma	0.000698	0.00145	CcSEcCtD
Topotecan—Asthenia—Apraclonidine—glaucoma	0.000697	0.00145	CcSEcCtD
Topotecan—Decreased appetite—Dorzolamide—glaucoma	0.000692	0.00144	CcSEcCtD
Topotecan—Urticaria—Acetazolamide—glaucoma	0.00069	0.00143	CcSEcCtD
Topotecan—Dyspepsia—Brinzolamide—glaucoma	0.000689	0.00143	CcSEcCtD
Topotecan—Pruritus—Apraclonidine—glaucoma	0.000687	0.00143	CcSEcCtD
Topotecan—Body temperature increased—Acetazolamide—glaucoma	0.000687	0.00142	CcSEcCtD
Topotecan—Fatigue—Dorzolamide—glaucoma	0.000687	0.00142	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000686	0.00142	CcSEcCtD
Topotecan—Gastrointestinal disorder—Travoprost—glaucoma	0.000685	0.00142	CcSEcCtD
Topotecan—Fatigue—Travoprost—glaucoma	0.000684	0.00142	CcSEcCtD
Topotecan—Ill-defined disorder—Clonidine—glaucoma	0.000683	0.00142	CcSEcCtD
Topotecan—Pain—Dorzolamide—glaucoma	0.000681	0.00141	CcSEcCtD
Topotecan—Decreased appetite—Brinzolamide—glaucoma	0.000681	0.00141	CcSEcCtD
Topotecan—Constipation—Travoprost—glaucoma	0.000678	0.00141	CcSEcCtD
Topotecan—Pain—Travoprost—glaucoma	0.000678	0.00141	CcSEcCtD
Topotecan—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000676	0.0014	CcSEcCtD
Topotecan—Paraesthesia—Pilocarpine—glaucoma	0.000676	0.0014	CcSEcCtD
Topotecan—Asthenia—Bimatoprost—glaucoma	0.000676	0.0014	CcSEcCtD
Topotecan—Fatigue—Brinzolamide—glaucoma	0.000675	0.0014	CcSEcCtD
Topotecan—Angioedema—Clonidine—glaucoma	0.000673	0.0014	CcSEcCtD
Topotecan—Dyspnoea—Pilocarpine—glaucoma	0.000671	0.00139	CcSEcCtD
Topotecan—Pain—Brinzolamide—glaucoma	0.000669	0.00139	CcSEcCtD
Topotecan—Angiopathy—Betaxolol—glaucoma	0.000668	0.00139	CcSEcCtD
Topotecan—Pruritus—Bimatoprost—glaucoma	0.000666	0.00138	CcSEcCtD
Topotecan—Immune system disorder—Betaxolol—glaucoma	0.000665	0.00138	CcSEcCtD
Topotecan—Diarrhoea—Apraclonidine—glaucoma	0.000665	0.00138	CcSEcCtD
Topotecan—Malaise—Clonidine—glaucoma	0.000664	0.00138	CcSEcCtD
Topotecan—Mediastinal disorder—Betaxolol—glaucoma	0.000664	0.00138	CcSEcCtD
Topotecan—Dyspepsia—Pilocarpine—glaucoma	0.000662	0.00137	CcSEcCtD
Topotecan—Chills—Betaxolol—glaucoma	0.000661	0.00137	CcSEcCtD
Topotecan—Feeling abnormal—Dorzolamide—glaucoma	0.000656	0.00136	CcSEcCtD
Topotecan—Decreased appetite—Pilocarpine—glaucoma	0.000654	0.00136	CcSEcCtD
Topotecan—Feeling abnormal—Travoprost—glaucoma	0.000653	0.00136	CcSEcCtD
Topotecan—Gastrointestinal pain—Dorzolamide—glaucoma	0.000651	0.00135	CcSEcCtD
Topotecan—Alopecia—Betaxolol—glaucoma	0.000651	0.00135	CcSEcCtD
Topotecan—Gastrointestinal disorder—Pilocarpine—glaucoma	0.00065	0.00135	CcSEcCtD
Topotecan—Gastrointestinal pain—Travoprost—glaucoma	0.000648	0.00135	CcSEcCtD
Topotecan—Feeling abnormal—Brinzolamide—glaucoma	0.000645	0.00134	CcSEcCtD
Topotecan—Pain—Pilocarpine—glaucoma	0.000643	0.00134	CcSEcCtD
Topotecan—Constipation—Pilocarpine—glaucoma	0.000643	0.00134	CcSEcCtD
Topotecan—Cough—Clonidine—glaucoma	0.000642	0.00133	CcSEcCtD
Topotecan—Sweating—Timolol—glaucoma	0.000642	0.00133	CcSEcCtD
Topotecan—Dizziness—Apraclonidine—glaucoma	0.000642	0.00133	CcSEcCtD
Topotecan—Malnutrition—Betaxolol—glaucoma	0.000641	0.00133	CcSEcCtD
Topotecan—Urticaria—Dorzolamide—glaucoma	0.000633	0.00131	CcSEcCtD
Topotecan—Epistaxis—Timolol—glaucoma	0.000632	0.00131	CcSEcCtD
Topotecan—Abdominal pain—Dorzolamide—glaucoma	0.000629	0.00131	CcSEcCtD
Topotecan—Body temperature increased—Dorzolamide—glaucoma	0.000629	0.00131	CcSEcCtD
Topotecan—Chest pain—Clonidine—glaucoma	0.000627	0.0013	CcSEcCtD
Topotecan—Arthralgia—Clonidine—glaucoma	0.000627	0.0013	CcSEcCtD
Topotecan—Abdominal pain—Travoprost—glaucoma	0.000627	0.0013	CcSEcCtD
Topotecan—Asthenia—Acetazolamide—glaucoma	0.000623	0.00129	CcSEcCtD
Topotecan—Dizziness—Bimatoprost—glaucoma	0.000623	0.00129	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000622	0.00129	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000622	0.0303	CbGpPWpGaD
Topotecan—Urticaria—Brinzolamide—glaucoma	0.000622	0.00129	CcSEcCtD
Topotecan—Feeling abnormal—Pilocarpine—glaucoma	0.00062	0.00129	CcSEcCtD
Topotecan—Discomfort—Clonidine—glaucoma	0.000619	0.00128	CcSEcCtD
Topotecan—Vomiting—Apraclonidine—glaucoma	0.000618	0.00128	CcSEcCtD
Topotecan—Muscle spasms—Betaxolol—glaucoma	0.000616	0.00128	CcSEcCtD
Topotecan—Gastrointestinal pain—Pilocarpine—glaucoma	0.000615	0.00128	CcSEcCtD
Topotecan—Hypersensitivity—Brimonidine—glaucoma	0.000614	0.00127	CcSEcCtD
Topotecan—Dermatitis—Apraclonidine—glaucoma	0.000612	0.00127	CcSEcCtD
Topotecan—Headache—Apraclonidine—glaucoma	0.000608	0.00126	CcSEcCtD
Topotecan—Rhinitis—Timolol—glaucoma	0.000603	0.00125	CcSEcCtD
Topotecan—Asthenia—Brimonidine—glaucoma	0.000598	0.00124	CcSEcCtD
Topotecan—Infection—Clonidine—glaucoma	0.000597	0.00124	CcSEcCtD
Topotecan—Body temperature increased—Pilocarpine—glaucoma	0.000595	0.00123	CcSEcCtD
Topotecan—Abdominal pain—Pilocarpine—glaucoma	0.000595	0.00123	CcSEcCtD
Topotecan—Ill-defined disorder—Betaxolol—glaucoma	0.000595	0.00123	CcSEcCtD
Topotecan—Diarrhoea—Acetazolamide—glaucoma	0.000594	0.00123	CcSEcCtD
Topotecan—Rash—Bimatoprost—glaucoma	0.000594	0.00123	CcSEcCtD
Topotecan—Dermatitis—Bimatoprost—glaucoma	0.000593	0.00123	CcSEcCtD
Topotecan—Anaemia—Betaxolol—glaucoma	0.000592	0.00123	CcSEcCtD
Topotecan—Pruritus—Brimonidine—glaucoma	0.00059	0.00122	CcSEcCtD
Topotecan—Headache—Bimatoprost—glaucoma	0.00059	0.00122	CcSEcCtD
Topotecan—Nervous system disorder—Clonidine—glaucoma	0.000589	0.00122	CcSEcCtD
Topotecan—Thrombocytopenia—Clonidine—glaucoma	0.000588	0.00122	CcSEcCtD
Topotecan—Hypersensitivity—Dorzolamide—glaucoma	0.000587	0.00122	CcSEcCtD
Topotecan—Hypersensitivity—Travoprost—glaucoma	0.000584	0.00121	CcSEcCtD
Topotecan—Skin disorder—Clonidine—glaucoma	0.000584	0.00121	CcSEcCtD
Topotecan—Hyperhidrosis—Clonidine—glaucoma	0.000581	0.00121	CcSEcCtD
Topotecan—Malaise—Betaxolol—glaucoma	0.000578	0.0012	CcSEcCtD
Topotecan—Nausea—Apraclonidine—glaucoma	0.000577	0.0012	CcSEcCtD
Topotecan—Hypersensitivity—Brinzolamide—glaucoma	0.000577	0.0012	CcSEcCtD
Topotecan—Dizziness—Acetazolamide—glaucoma	0.000574	0.00119	CcSEcCtD
Topotecan—Anorexia—Clonidine—glaucoma	0.000573	0.00119	CcSEcCtD
Topotecan—Asthenia—Dorzolamide—glaucoma	0.000571	0.00119	CcSEcCtD
Topotecan—Asthenia—Travoprost—glaucoma	0.000569	0.00118	CcSEcCtD
Topotecan—Pruritus—Dorzolamide—glaucoma	0.000563	0.00117	CcSEcCtD
Topotecan—Asthenia—Brinzolamide—glaucoma	0.000562	0.00117	CcSEcCtD
Topotecan—Pruritus—Travoprost—glaucoma	0.000561	0.00116	CcSEcCtD
Topotecan—Cough—Betaxolol—glaucoma	0.000559	0.00116	CcSEcCtD
Topotecan—Nausea—Bimatoprost—glaucoma	0.000559	0.00116	CcSEcCtD
Topotecan—Hypersensitivity—Pilocarpine—glaucoma	0.000554	0.00115	CcSEcCtD
Topotecan—Pruritus—Brinzolamide—glaucoma	0.000554	0.00115	CcSEcCtD
Topotecan—Vomiting—Acetazolamide—glaucoma	0.000552	0.00115	CcSEcCtD
Topotecan—Dizziness—Brimonidine—glaucoma	0.000551	0.00114	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Clonidine—glaucoma	0.000547	0.00114	CcSEcCtD
Topotecan—Angiopathy—Timolol—glaucoma	0.000546	0.00113	CcSEcCtD
Topotecan—Chest pain—Betaxolol—glaucoma	0.000546	0.00113	CcSEcCtD
Topotecan—Myalgia—Betaxolol—glaucoma	0.000546	0.00113	CcSEcCtD
Topotecan—Arthralgia—Betaxolol—glaucoma	0.000546	0.00113	CcSEcCtD
Topotecan—Diarrhoea—Dorzolamide—glaucoma	0.000545	0.00113	CcSEcCtD
Topotecan—Headache—Acetazolamide—glaucoma	0.000544	0.00113	CcSEcCtD
Topotecan—Immune system disorder—Timolol—glaucoma	0.000543	0.00113	CcSEcCtD
Topotecan—Diarrhoea—Travoprost—glaucoma	0.000542	0.00113	CcSEcCtD
Topotecan—Mediastinal disorder—Timolol—glaucoma	0.000542	0.00112	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000542	0.00112	CcSEcCtD
Topotecan—Asthenia—Pilocarpine—glaucoma	0.00054	0.00112	CcSEcCtD
Topotecan—Paraesthesia—Clonidine—glaucoma	0.00054	0.00112	CcSEcCtD
Topotecan—Discomfort—Betaxolol—glaucoma	0.000539	0.00112	CcSEcCtD
Topotecan—Dyspnoea—Clonidine—glaucoma	0.000536	0.00111	CcSEcCtD
Topotecan—Diarrhoea—Brinzolamide—glaucoma	0.000536	0.00111	CcSEcCtD
Topotecan—Pruritus—Pilocarpine—glaucoma	0.000532	0.0011	CcSEcCtD
Topotecan—Alopecia—Timolol—glaucoma	0.000532	0.0011	CcSEcCtD
Topotecan—Dizziness—Dorzolamide—glaucoma	0.000527	0.00109	CcSEcCtD
Topotecan—Rash—Brimonidine—glaucoma	0.000526	0.00109	CcSEcCtD
Topotecan—Dermatitis—Brimonidine—glaucoma	0.000525	0.00109	CcSEcCtD
Topotecan—Dizziness—Travoprost—glaucoma	0.000524	0.00109	CcSEcCtD
Topotecan—Malnutrition—Timolol—glaucoma	0.000524	0.00109	CcSEcCtD
Topotecan—Headache—Brimonidine—glaucoma	0.000522	0.00108	CcSEcCtD
Topotecan—Decreased appetite—Clonidine—glaucoma	0.000522	0.00108	CcSEcCtD
Topotecan—Infection—Betaxolol—glaucoma	0.00052	0.00108	CcSEcCtD
Topotecan—Gastrointestinal disorder—Clonidine—glaucoma	0.000519	0.00108	CcSEcCtD
Topotecan—Fatigue—Clonidine—glaucoma	0.000518	0.00107	CcSEcCtD
Topotecan—Dizziness—Brinzolamide—glaucoma	0.000518	0.00107	CcSEcCtD
Topotecan—Nausea—Acetazolamide—glaucoma	0.000516	0.00107	CcSEcCtD
Topotecan—Diarrhoea—Pilocarpine—glaucoma	0.000515	0.00107	CcSEcCtD
Topotecan—Constipation—Clonidine—glaucoma	0.000514	0.00107	CcSEcCtD
Topotecan—Pain—Clonidine—glaucoma	0.000514	0.00107	CcSEcCtD
Topotecan—Nervous system disorder—Betaxolol—glaucoma	0.000513	0.00106	CcSEcCtD
Topotecan—Thrombocytopenia—Betaxolol—glaucoma	0.000512	0.00106	CcSEcCtD
Topotecan—Skin disorder—Betaxolol—glaucoma	0.000508	0.00105	CcSEcCtD
Topotecan—Vomiting—Dorzolamide—glaucoma	0.000506	0.00105	CcSEcCtD
Topotecan—Hyperhidrosis—Betaxolol—glaucoma	0.000506	0.00105	CcSEcCtD
Topotecan—Rash—Dorzolamide—glaucoma	0.000502	0.00104	CcSEcCtD
Topotecan—Dermatitis—Dorzolamide—glaucoma	0.000502	0.00104	CcSEcCtD
Topotecan—Rash—Travoprost—glaucoma	0.0005	0.00104	CcSEcCtD
Topotecan—Dermatitis—Travoprost—glaucoma	0.000499	0.00104	CcSEcCtD
Topotecan—Headache—Dorzolamide—glaucoma	0.000499	0.00104	CcSEcCtD
Topotecan—Anorexia—Betaxolol—glaucoma	0.000499	0.00103	CcSEcCtD
Topotecan—Vomiting—Brinzolamide—glaucoma	0.000498	0.00103	CcSEcCtD
Topotecan—Dizziness—Pilocarpine—glaucoma	0.000498	0.00103	CcSEcCtD
Topotecan—Headache—Travoprost—glaucoma	0.000497	0.00103	CcSEcCtD
Topotecan—Nausea—Brimonidine—glaucoma	0.000495	0.00103	CcSEcCtD
Topotecan—Feeling abnormal—Clonidine—glaucoma	0.000495	0.00103	CcSEcCtD
Topotecan—Rash—Brinzolamide—glaucoma	0.000494	0.00102	CcSEcCtD
Topotecan—Dermatitis—Brinzolamide—glaucoma	0.000493	0.00102	CcSEcCtD
Topotecan—Gastrointestinal pain—Clonidine—glaucoma	0.000491	0.00102	CcSEcCtD
Topotecan—Headache—Brinzolamide—glaucoma	0.00049	0.00102	CcSEcCtD
Topotecan—Angioedema—Timolol—glaucoma	0.000478	0.000993	CcSEcCtD
Topotecan—Vomiting—Pilocarpine—glaucoma	0.000478	0.000993	CcSEcCtD
Topotecan—Urticaria—Clonidine—glaucoma	0.000477	0.00099	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000477	0.000989	CcSEcCtD
Topotecan—Body temperature increased—Clonidine—glaucoma	0.000475	0.000986	CcSEcCtD
Topotecan—Abdominal pain—Clonidine—glaucoma	0.000475	0.000986	CcSEcCtD
Topotecan—Rash—Pilocarpine—glaucoma	0.000474	0.000984	CcSEcCtD
Topotecan—Dermatitis—Pilocarpine—glaucoma	0.000474	0.000983	CcSEcCtD
Topotecan—Nausea—Dorzolamide—glaucoma	0.000473	0.000981	CcSEcCtD
Topotecan—Headache—Pilocarpine—glaucoma	0.000471	0.000978	CcSEcCtD
Topotecan—Nausea—Travoprost—glaucoma	0.000471	0.000977	CcSEcCtD
Topotecan—Paraesthesia—Betaxolol—glaucoma	0.00047	0.000975	CcSEcCtD
Topotecan—TOP1—Circadian rythm related genes—NGFR—glaucoma	0.000469	0.0228	CbGpPWpGaD
Topotecan—Dyspnoea—Betaxolol—glaucoma	0.000466	0.000968	CcSEcCtD
Topotecan—Nausea—Brinzolamide—glaucoma	0.000465	0.000965	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000464	0.0226	CbGpPWpGaD
Topotecan—Dyspepsia—Betaxolol—glaucoma	0.00046	0.000955	CcSEcCtD
Topotecan—Cough—Timolol—glaucoma	0.000457	0.000948	CcSEcCtD
Topotecan—Decreased appetite—Betaxolol—glaucoma	0.000455	0.000944	CcSEcCtD
Topotecan—Gastrointestinal disorder—Betaxolol—glaucoma	0.000452	0.000937	CcSEcCtD
Topotecan—Fatigue—Betaxolol—glaucoma	0.000451	0.000936	CcSEcCtD
Topotecan—Pain—Betaxolol—glaucoma	0.000447	0.000928	CcSEcCtD
Topotecan—Constipation—Betaxolol—glaucoma	0.000447	0.000928	CcSEcCtD
Topotecan—Nausea—Pilocarpine—glaucoma	0.000447	0.000927	CcSEcCtD
Topotecan—Myalgia—Timolol—glaucoma	0.000446	0.000925	CcSEcCtD
Topotecan—Arthralgia—Timolol—glaucoma	0.000446	0.000925	CcSEcCtD
Topotecan—Chest pain—Timolol—glaucoma	0.000446	0.000925	CcSEcCtD
Topotecan—TOP1—Circadian rythm related genes—NTRK1—glaucoma	0.000445	0.0217	CbGpPWpGaD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000443	0.000919	CcSEcCtD
Topotecan—Hypersensitivity—Clonidine—glaucoma	0.000443	0.000919	CcSEcCtD
Topotecan—Discomfort—Timolol—glaucoma	0.00044	0.000914	CcSEcCtD
Topotecan—Asthenia—Clonidine—glaucoma	0.000431	0.000895	CcSEcCtD
Topotecan—Feeling abnormal—Betaxolol—glaucoma	0.000431	0.000894	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000428	0.0208	CbGpPWpGaD
Topotecan—Anaphylactic shock—Timolol—glaucoma	0.000427	0.000887	CcSEcCtD
Topotecan—Pruritus—Clonidine—glaucoma	0.000425	0.000882	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000425	0.0207	CbGpPWpGaD
Topotecan—Infection—Timolol—glaucoma	0.000425	0.000881	CcSEcCtD
Topotecan—Nervous system disorder—Timolol—glaucoma	0.000419	0.00087	CcSEcCtD
Topotecan—Urticaria—Betaxolol—glaucoma	0.000416	0.000862	CcSEcCtD
Topotecan—Skin disorder—Timolol—glaucoma	0.000415	0.000861	CcSEcCtD
Topotecan—Body temperature increased—Betaxolol—glaucoma	0.000414	0.000858	CcSEcCtD
Topotecan—Hyperhidrosis—Timolol—glaucoma	0.000413	0.000857	CcSEcCtD
Topotecan—Diarrhoea—Clonidine—glaucoma	0.000411	0.000853	CcSEcCtD
Topotecan—Anorexia—Timolol—glaucoma	0.000407	0.000845	CcSEcCtD
Topotecan—TOP1—Caspase Cascade in Apoptosis—TNF—glaucoma	0.000406	0.0198	CbGpPWpGaD
Topotecan—Dizziness—Clonidine—glaucoma	0.000397	0.000824	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Timolol—glaucoma	0.000389	0.000808	CcSEcCtD
Topotecan—Hypersensitivity—Betaxolol—glaucoma	0.000385	0.0008	CcSEcCtD
Topotecan—Paraesthesia—Timolol—glaucoma	0.000384	0.000796	CcSEcCtD
Topotecan—Vomiting—Clonidine—glaucoma	0.000382	0.000793	CcSEcCtD
Topotecan—Dyspnoea—Timolol—glaucoma	0.000381	0.000791	CcSEcCtD
Topotecan—Rash—Clonidine—glaucoma	0.000379	0.000786	CcSEcCtD
Topotecan—Dermatitis—Clonidine—glaucoma	0.000379	0.000785	CcSEcCtD
Topotecan—Headache—Clonidine—glaucoma	0.000376	0.000781	CcSEcCtD
Topotecan—Dyspepsia—Timolol—glaucoma	0.000376	0.000781	CcSEcCtD
Topotecan—Asthenia—Betaxolol—glaucoma	0.000375	0.000779	CcSEcCtD
Topotecan—Decreased appetite—Timolol—glaucoma	0.000372	0.000771	CcSEcCtD
Topotecan—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.00037	0.018	CbGpPWpGaD
Topotecan—Pruritus—Betaxolol—glaucoma	0.00037	0.000768	CcSEcCtD
Topotecan—Gastrointestinal disorder—Timolol—glaucoma	0.000369	0.000766	CcSEcCtD
Topotecan—Fatigue—Timolol—glaucoma	0.000368	0.000765	CcSEcCtD
Topotecan—Pain—Timolol—glaucoma	0.000365	0.000758	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000364	0.0177	CbGpPWpGaD
Topotecan—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000362	0.0176	CbGpPWpGaD
Topotecan—Diarrhoea—Betaxolol—glaucoma	0.000358	0.000743	CcSEcCtD
Topotecan—Nausea—Clonidine—glaucoma	0.000357	0.000741	CcSEcCtD
Topotecan—Feeling abnormal—Timolol—glaucoma	0.000352	0.000731	CcSEcCtD
Topotecan—Gastrointestinal pain—Timolol—glaucoma	0.000349	0.000725	CcSEcCtD
Topotecan—TOP1—Circadian rythm related genes—FAS—glaucoma	0.000349	0.017	CbGpPWpGaD
Topotecan—Dizziness—Betaxolol—glaucoma	0.000346	0.000718	CcSEcCtD
Topotecan—Urticaria—Timolol—glaucoma	0.00034	0.000704	CcSEcCtD
Topotecan—Abdominal pain—Timolol—glaucoma	0.000338	0.000701	CcSEcCtD
Topotecan—Body temperature increased—Timolol—glaucoma	0.000338	0.000701	CcSEcCtD
Topotecan—Vomiting—Betaxolol—glaucoma	0.000333	0.00069	CcSEcCtD
Topotecan—Rash—Betaxolol—glaucoma	0.00033	0.000684	CcSEcCtD
Topotecan—Dermatitis—Betaxolol—glaucoma	0.00033	0.000684	CcSEcCtD
Topotecan—Headache—Betaxolol—glaucoma	0.000328	0.00068	CcSEcCtD
Topotecan—Hypersensitivity—Timolol—glaucoma	0.000315	0.000653	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.000311	0.0151	CbGpPWpGaD
Topotecan—Nausea—Betaxolol—glaucoma	0.000311	0.000645	CcSEcCtD
Topotecan—Asthenia—Timolol—glaucoma	0.000307	0.000636	CcSEcCtD
Topotecan—Pruritus—Timolol—glaucoma	0.000302	0.000627	CcSEcCtD
Topotecan—Diarrhoea—Timolol—glaucoma	0.000292	0.000607	CcSEcCtD
Topotecan—Dizziness—Timolol—glaucoma	0.000283	0.000586	CcSEcCtD
Topotecan—ABCG2—Fluoropyrimidine Activity—MTHFR—glaucoma	0.000278	0.0135	CbGpPWpGaD
Topotecan—Vomiting—Timolol—glaucoma	0.000272	0.000564	CcSEcCtD
Topotecan—Rash—Timolol—glaucoma	0.000269	0.000559	CcSEcCtD
Topotecan—Dermatitis—Timolol—glaucoma	0.000269	0.000559	CcSEcCtD
Topotecan—Headache—Timolol—glaucoma	0.000268	0.000556	CcSEcCtD
Topotecan—Nausea—Timolol—glaucoma	0.000254	0.000527	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.000229	0.0111	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.000228	0.0111	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.000217	0.0105	CbGpPWpGaD
Topotecan—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000213	0.0103	CbGpPWpGaD
Topotecan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000208	0.0101	CbGpPWpGaD
Topotecan—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000188	0.00915	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—EDN1—glaucoma	0.000183	0.00889	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.00018	0.00876	CbGpPWpGaD
Topotecan—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.00017	0.00827	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—PEX19—glaucoma	0.000168	0.00815	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	0.000154	0.00751	CbGpPWpGaD
Topotecan—ABCG2—HIF-2-alpha transcription factor network—VEGFA—glaucoma	0.000136	0.00663	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	0.000136	0.00662	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—TP53—glaucoma	0.000131	0.00636	CbGpPWpGaD
Topotecan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000128	0.00622	CbGpPWpGaD
Topotecan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	0.000122	0.00595	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000113	0.00551	CbGpPWpGaD
Topotecan—ABCG2—Fluoropyrimidine Activity—TP53—glaucoma	0.000105	0.00513	CbGpPWpGaD
Topotecan—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.0001	0.00489	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—EDN1—glaucoma	9.88e-05	0.0048	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CA5A—glaucoma	9.23e-05	0.00449	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—NARFL—glaucoma	9.23e-05	0.00449	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—PEX19—glaucoma	9.06e-05	0.00441	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—IL1A—glaucoma	8.5e-05	0.00414	CbGpPWpGaD
Topotecan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	8.12e-05	0.00395	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—VEGFA—glaucoma	8.02e-05	0.0039	CbGpPWpGaD
Topotecan—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	8.01e-05	0.0039	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—FAS—glaucoma	7.58e-05	0.00369	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—SLC6A13—glaucoma	7.55e-05	0.00368	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—C3—glaucoma	7.47e-05	0.00364	CbGpPWpGaD
Topotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	6.62e-05	0.00322	CbGpPWpGaD
Topotecan—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	6.58e-05	0.0032	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	6.4e-05	0.00311	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	6.12e-05	0.00298	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—SLC6A1—glaucoma	5.53e-05	0.00269	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NARFL—glaucoma	4.99e-05	0.00243	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CA5A—glaucoma	4.99e-05	0.00243	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	4.77e-05	0.00232	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CA1—glaucoma	4.51e-05	0.00219	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	4.4e-05	0.00214	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—GSTT1—glaucoma	4.39e-05	0.00213	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	4.37e-05	0.00213	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CTSA—glaucoma	4.37e-05	0.00212	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	4.34e-05	0.00211	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CA2—glaucoma	4.12e-05	0.00201	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	4.08e-05	0.00199	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—VEGFA—glaucoma	3.75e-05	0.00183	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	3.74e-05	0.00182	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—CYP1B1—glaucoma	3.5e-05	0.0017	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	3.45e-05	0.00168	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—TNF—glaucoma	3.22e-05	0.00157	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	3.2e-05	0.00156	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CA5A—glaucoma	3.08e-05	0.0015	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NARFL—glaucoma	3.08e-05	0.0015	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	2.99e-05	0.00145	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—TXN—glaucoma	2.91e-05	0.00141	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—GSTM1—glaucoma	2.8e-05	0.00136	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	2.76e-05	0.00134	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CA1—glaucoma	2.44e-05	0.00119	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CTSA—glaucoma	2.36e-05	0.00115	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	2.35e-05	0.00114	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GSTT1—glaucoma	2.25e-05	0.0011	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CA2—glaucoma	2.23e-05	0.00108	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	2.23e-05	0.00108	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	1.85e-05	0.000901	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ABCA1—glaucoma	1.8e-05	0.000873	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP1B1—glaucoma	1.8e-05	0.000873	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	1.59e-05	0.000773	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—TXN—glaucoma	1.57e-05	0.000764	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CA1—glaucoma	1.5e-05	0.000731	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CTSA—glaucoma	1.45e-05	0.000708	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GSTM1—glaucoma	1.44e-05	0.000698	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	1.4e-05	0.000681	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CA2—glaucoma	1.37e-05	0.000668	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—MTHFR—glaucoma	1.27e-05	0.000617	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GSTT1—glaucoma	1.22e-05	0.000593	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—APOE—glaucoma	1.18e-05	0.000574	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CAV1—glaucoma	1.17e-05	0.000569	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP1B1—glaucoma	9.71e-06	0.000472	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ABCA1—glaucoma	9.71e-06	0.000472	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—TXN—glaucoma	9.68e-06	0.000471	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—NOS3—glaucoma	8.85e-06	0.00043	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PTGS2—glaucoma	8.09e-06	0.000394	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GSTM1—glaucoma	7.76e-06	0.000377	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GSTT1—glaucoma	7.5e-06	0.000365	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—MTHFR—glaucoma	6.86e-06	0.000334	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—APOE—glaucoma	6.38e-06	0.000311	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CAV1—glaucoma	6.33e-06	0.000308	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ABCA1—glaucoma	5.98e-06	0.000291	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP1B1—glaucoma	5.98e-06	0.000291	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NOS3—glaucoma	4.78e-06	0.000233	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GSTM1—glaucoma	4.78e-06	0.000233	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PTGS2—glaucoma	4.37e-06	0.000213	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—MTHFR—glaucoma	4.22e-06	0.000206	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—APOE—glaucoma	3.93e-06	0.000191	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CAV1—glaucoma	3.9e-06	0.00019	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NOS3—glaucoma	2.95e-06	0.000143	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PTGS2—glaucoma	2.69e-06	0.000131	CbGpPWpGaD
